Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial evaluating the efficacy and safety of AFQ056 to reduce L-dopa-induced dyskinesias in Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease [Phase 3]
A Phase 3 clinical trial evaluated the role of the noradrenergic system in pain perception in Parkinson's disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Effect of Levodopa on Postural Motor Learning in Parkinson Disease
This clinical trial update reports results evaluating the effect of levodopa on postural motor learning in Parkinson disease. The study is c…
-
CLINICAL_TRIALS research · 2017-02-23Clinical Trial Update: Movement Disorder Quantification Algorithm Development
A completed clinical trial update on developing a quantitative movement disorder assessment algorithm for Parkinson's disease and essential …
-
CLINICAL_TRIALS withdrawal · 2017-02-23Clinical Trial Update: Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD) [NA]
A clinical trial investigating a novel mobile cognitive tracking and training tool for Parkinson's disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2017-02-23Clinical Trial Update: Motor Control During Rapid Eye Movement (REM) Sleep Behaviour Disorder [NA]
A clinical trial studying motor control during REM sleep behavior disorder in Parkinson disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: CUSTOM-DBS: Current Steering to Optimize Deep Brain Stimulation [NA]
A completed clinical trial update for CUSTOM-DBS studying current steering to optimize deep brain stimulation in Parkinson's disease with re…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Transcutaneous Electric Nerve Stimulation in Sleep of Patients With Parkinson's Disease [NA]
This clinical trial update reports a completed study evaluating transcutaneous electrical nerve stimulation to improve sleep in patients wit…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Virtual Reality in Parkinson Disease [NA]
A clinical trial evaluating virtual reality therapy for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders [Phase 2, Phase 3]
The completed Phase 2/3 trial evaluated 18F-AV-133 PET imaging for distinguishing Parkinson's disease from other movement disorders.
-
CLINICAL_TRIALS research · 2017-02-09Clinical Trial Update: Evolution of RBD in PD [NA]
Ongoing clinical study from University Hospital in Clermont-Ferrand examining the evolution of REM Sleep Behavior Disorder in patients with …
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Dyskinesia in Parkinson's Disease (Study P04501) [Phase 2]
Phase 2 clinical trial update on dyskinesia in Parkinson's disease (Study P04501) completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease [Phase 3]
Phase 3 trial evaluating safety and efficacy of Levodopa-carbidopa intestinal gel (LCIG) for non-motor symptoms in advanced Parkinson's dise…
-
CLINICAL_TRIALS withdrawal · 2017-02-07Clinical Trial Update: Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
A Phase 2 trial of incobotulinum toxin A for sialorrhea in Parkinson disease and amyotrophic lateral sclerosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying [Phase 2]
Phase 2 study assessing repeat dosing of GSK962040 on the pharmacokinetics of L-DOPA in Parkinson's disease patients with delayed gastric em…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Erythromycin in Parkinson's Disease [NA]
A clinical trial evaluating erythromycin in Parkinson's disease has completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Computerized Cognitive Behavioral Therapy Trial for Insomnia in Parkinson Disease [NA]
A Cleveland Clinic-sponsored trial evaluating computerized cognitive behavioral therapy for insomnia in Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Cognitive Phenotypes in Parkinson's Disease
The entry reports the completion of a clinical trial studying cognitive phenotypes in Parkinson disease; no pharmacological interventions ar…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease [NA]
This completed clinical trial evaluated MR-guided subthalamotomy with the ExAblate Transcranial System for motor features of Parkinson's dis…
-
FDA approval · 2017-01-30FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA has approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc. No specific changes are detailed in the excer…
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder) [Phase 1]
A Phase 1 study evaluated the safety and tolerability of a single-dose inhaled levodopa powder (CVT-301) for Parkinson's disease; the trial …
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Visual Function During Gait in Parkinson's Disease: Impact of Cognition and Response to Visual Cues
This clinical trial update reports on a completed study evaluating visual function during gait in Parkinson's disease and how cognition and …
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes [NA]
Connect.Parkinson studied delivering Parkinson disease care to patients in their homes; the trial is completed and results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Behavioural Addiction and Genetics in Parkinson's Disease
This completed clinical trial investigates behavioural addiction and genetic factors in Parkinson's disease, including its relation to impul…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Freezing of Gait in Parkinson's Disease [NA]
The clinical trial studying freezing of gait in Parkinson disease sponsored by Duke University has completed.